Clinical Impact of Rapid Identification of Positive Blood Cultures vs. Internal Laboratory Standard

CompletedOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

October 17, 2019

Primary Completion Date

March 1, 2022

Study Completion Date

July 31, 2022

Conditions
Bloodstream Infections
Interventions
DIAGNOSTIC_TEST

conventional identification method: biochemical profiling or MALDI-TOF MS

Identification of bacteria in positive blood cultures with MALDI-TOF MS from a subculture usually one day after the signal for a positive blood culture appears (from 2016 to 2018)

DIAGNOSTIC_TEST

new identification method: Biofire FilmArray© BCID panel

The Biofire FilmArray© BCID Panel is performed directly from the positive blood culture without the need of subculture to reach single bacterial colonies (from 2018 and 2019)

DIAGNOSTIC_TEST

new identification method: metagenomic WGS

shotgun metagenomic approach allows to sequence the whole genome (WGS) of pathogens and thereby potentially detect every potential pathogen and also resistance and virulence gene (from 2018 and 2019)

Trial Locations (1)

4031

Division of Clinical Bacteriology & Mycology, University Hospital Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT04156633 - Clinical Impact of Rapid Identification of Positive Blood Cultures vs. Internal Laboratory Standard | Biotech Hunter | Biotech Hunter